Maher Masoud
Vorstandsvorsitzender bei MAXCYTE, INC.
Vermögen: - $ am 30.04.2024
Profil
Maher Masoud is currently the President, Chief Executive Officer & Director at MaxCyte, Inc. He is also a Member of the Maryland State Bar Association.
Previously, he worked as a Corporate Attorney at Human Genome Sciences, Inc. from 2006 to 2012, and as the Secretary & Assistant General Counsel at Wellstat Management Co. LLC from 2015 to 2017.
Mr. Masoud completed his undergraduate studies at the University of Maryland and his graduate studies at Michigan State University College of Law.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
MAXCYTE, INC.
-.--% | 03.01.2024 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Maher Masoud
| Unternehmen | Position | Beginn |
|---|---|---|
| MAXCYTE, INC. | Vorstandsvorsitzender | 01.01.2024 |
| Maryland State Bar Association | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Maher Masoud
| Unternehmen | Position | Ende |
|---|---|---|
Wellstat Management Co. LLC
 Wellstat Management Co. LLC Miscellaneous Commercial ServicesCommercial Services Wellstat Management Co. LLC provides management, legal, financial, human resources, information technology, business development, transactional, investment, licensing, and other services to the Wellstat group of companies. The company was founded by Samuel J. Wohlstadter in 2007 and is headquartered in Rockville, MD. | Unternehmenssekretär | 01.01.2017 |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | 01.01.2012 |
Ausbildung von Maher Masoud
| University of Maryland | Undergraduate Degree |
| Michigan State University College of Law | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| MAXCYTE, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Health Technology |
| Maryland State Bar Association | |
Wellstat Management Co. LLC
Wellstat Management Co. LLC Miscellaneous Commercial ServicesCommercial Services Wellstat Management Co. LLC provides management, legal, financial, human resources, information technology, business development, transactional, investment, licensing, and other services to the Wellstat group of companies. The company was founded by Samuel J. Wohlstadter in 2007 and is headquartered in Rockville, MD. | Commercial Services |
